Peripheral arterial disease, prevalence and cumulative risk factor profile analysis.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 4436703)

Published in Eur J Prev Cardiol on June 27, 2012

Authors

Luis H Eraso1, Eri Fukaya2, Emile R Mohler2, Dawei Xie3, Daohang Sha3, Jeffrey S Berger4

Author Affiliations

1: Jefferson Vascular Center, Departments of Medicine and Surgery, Thomas Jefferson University, Philadelphia, PA, USA luis.eraso@jefferson.edu.
2: Cardiovascular Division, Vascular Medicine Section, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
3: Departments of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
4: Cardiology, Hematology and Vascular Surgery, New York University School of Medicine, New York, NY, USA.

Associated clinical trials:

Platelet Activity in Vascular Surgery for Thrombosis and Bleeding (PIVOTAL) | NCT01897103

Articles cited by this

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation (2004) 7.30

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol (2006) 5.70

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27

Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37

Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol (2008) 2.38

Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation (1997) 2.29

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation (2003) 2.28

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol (1996) 2.25

Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis (2000) 2.05

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation (2003) 1.93

Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation (2003) 1.90

The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation (2006) 1.76

Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care (2009) 1.75

Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71

Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol (2007) 1.53

Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation (2011) 1.51

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation (2003) 1.51

Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation (2008) 1.34

Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg (2004) 1.09

Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis (2010) 1.08

Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev (2007) 1.07

Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med (2011) 1.02

Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease. Vasc Med (2009) 0.89

Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiovasc Prev Rehabil (2006) 0.88

Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease. Eur J Cardiovasc Prev Rehabil (2009) 0.87

Relationship between lipid parameters and the presence of peripheral arterial disease in elderly patients. Curr Med Res Opin (2004) 0.80